Could I have a statement, please? http://madeinkano.com.ng/cyprium-therapeutics-1cee.pdf#smartly cyprium partners new york  The truth is that a company's decision about where to list makes virtually no difference to anyone except to the two main exchanges themselves. To them it means a lot. They get annual fees from the listed companies -- up to $500,000 at the NYSE, $100,000 at Nasdaq -- as well as a minuscule vig from every trade.